Exelixis (EXEL) Research & Development (2010 - 2026)

Exelixis' Research & Development history runs 17 years deep, the most recent figure standing at $199.9 million for Q2 2026.

• On a quarterly basis, Research & Development fell 5.8% year-over-year to $199.9 million in Q2 2026; TTM through Apr 2026 was $812.7 million, a 9.19% decrease from a year earlier, with the FY2026 full-year figure at $825.0 million, down 9.38% from the prior year.
• Research & Development slipped to $199.9 million in Q2 2026 per EXEL's latest filing, from $213.2 million in the prior quarter.
• Across five years, Research & Development topped out at $336.8 million in Q4 2022 and bottomed at $156.7 million in Q2 2022.
• The 5-year median for Research & Development is $213.2 million (2026), against an average of $227.7 million.
• Across the five-year window, Research & Development jumped 512.41% in 2022 and tumbled 33.08% in 2024, its largest moves.
• Year by year, Research & Development stood at $336.8 million in 2022, then fell by 27.36% to $244.7 million in 2023, then fell by 9.03% to $222.6 million in 2024, then retreated by 10.52% to $199.2 million in 2025, then increased by 0.38% to $199.9 million in 2026.
• Per Business Quant, the three latest EXEL Research & Development figures stand at $199.9 million (Q2 2026), $213.2 million (Q1 2026), and $199.2 million (Q4 2025).